Literature DB >> 7766143

Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.

H Tachibana1, K Taniguchi, Y Ushio, K Teruya, K Osada, H Murakami.   

Abstract

The effect of glucose and other monosaccharide availability in culture medium on production of antibody by human hybridomas has been studied. Human hybridoma cells C5TN produce an anti lung cancer human monoclonal antibody, and the light chain is N-glycosylated at the variable region. When the cell line was grown in the presence of various concentrations of glucose, the antibodies produced changed their antigen-binding activities. Analysis of the light chains produced under these condition revealed that four molecular-mass variant light chains ranging from about 26 to 32 kDa were secreted. The twenty six-kDa species, which corresponds to a non-glycosylated form of the light chain, was recovered after enzymatic removal of all N-linked carbohydrate chains, indicating that the source of the heterogeneity of the light chain is due to the varied glycosylation. When the C5TN cells were cultured in medium containing either fructose, mannose or galactose instead of glucose, galactose elevated the antigen binding activity of the antibody more than the other sugars. These results suggest that change of glucose availability affects the antigen-binding activity of the antibody via the alteration of the glycosylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7766143     DOI: 10.1007/BF00749902

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  11 in total

1.  Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

Authors:  H Tachibana; K Akiyama; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells.

Authors:  N J Stark; E C Heath
Journal:  Arch Biochem Biophys       Date:  1979-02       Impact factor: 4.013

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.

Authors:  E M Curling; P M Hayter; A J Baines; A T Bull; K Gull; P G Strange; N Jenkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells.

Authors:  Y Kagawa; S Takasaki; J Utsumi; K Hosoi; H Shimizu; N Kochibe; A Kobata
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

7.  Identification of hybrid-type carbohydrate chains on the light chain of human monoclonal antibody specific to lung adenocarcinoma.

Authors:  H Tachibana; K Seki; H Murakami
Journal:  Biochim Biophys Acta       Date:  1993-10-20

8.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

9.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

10.  Serodiagnosis of cancer using porcine carboxypeptidase A as an animal antigen recognized by human monoclonal antibody HB4C5.

Authors:  S Hashizume; K Mochizuki; M Kamei; K Kuroda; M Kato; S Sato; K Yasumoto; H Nakahashi; K Tsuchimoto; M Muraoka
Journal:  Hum Antibodies Hybridomas       Date:  1991-04
View more
  7 in total

1.  Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures.

Authors:  H Tachibana; J Y Kim; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  Efficient production of recombinant IgG by metabolic control and co-expression with GLUT5 in a fructose-based medium.

Authors:  Yuichi Inoue; Yuriko Tsukamoto; Makoto Yamanaka; Shigeki Nakamura; Aiko Inoue; Norikazu Nishino; Hiroharu Kawahara
Journal:  Cytotechnology       Date:  2010-08-10       Impact factor: 2.058

3.  Modified antigen-binding of human antibodies with glycosylation variations of the light chains produced in sugar-limited human hybridoma cultures.

Authors:  H Tachibana; K Jiyoun; K Taniguchi; Y Ushio; K Teruya; K Osada; Y Inoue; S Shirahata; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

4.  Glycosylation of antibody in a lectin-resistant human hybridoma is insensitive to glucose.

Authors:  H Tachibana; Y Ushio; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

5.  The effect of nitrogen source on yield and glycosylation of a human cystatin C mutant expressed in Pichia pastoris.

Authors:  Jason Pritchett; Susan A Baldwin
Journal:  J Ind Microbiol Biotechnol       Date:  2004-11-18       Impact factor: 3.346

6.  Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.

Authors:  K Panneerselvam; H H Freeze
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

7.  On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape.

Authors:  Stacy Alyse Malaker; Jusal Quanico; Antonella Raffo-Romero; Firas Kobeissy; Soulaimane Aboulouard; Dominique Tierny; Carolyn Ruth Bertozzi; Isabelle Fournier; Michel Salzet
Journal:  Cell Chem Biol       Date:  2021-06-07       Impact factor: 8.116

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.